Editors' highlight picks from 2023 in ESC heart failure

Author:

Bäck Magnus123,von Haehling Stephan45,Papp Zoltán6ORCID,Piepoli Massimo F.78

Affiliation:

1. Translational Cardiology, Center for Molecular Medicine, Department of Medicine Solna Karolinska Institutet Stockholm Sweden

2. Department of Cardiology Karolinska University Hospital Stockholm Sweden

3. Institut National de la Sante et de la Recherche Medicale U1116 Université de Lorraine Nancy France

4. Department of Cardiology and Pneumology University of Göttingen Medical Center Göttingen Germany

5. German Center for Cardiovascular Research (DZHK) Partner Site Göttingen Göttingen Germany

6. Department of Cardiology, Division of Clinical Physiology, Faculty of Medicine University of Debrecen Debrecen Hungary

7. Department of Clinical Cardiology IRCCS Policlinico San Donato Milan Italy

8. Department of Preventive Cardiology Wroclaw Medical University Wrocław Poland

Abstract

AbstractHeart failure is a devastating syndrome affecting an increasingly high number of patients worldwide. Its aetiology and pathogenesis are complex with the involvement of factors ranging from the genetic material through valvular dysfunctions to numerous organs beyond the entire cardiovascular system. Based on continuous efforts of the heart failure scientific community we have witnessed major advances in many related disciplines during the last year. For example, epidemiological aspects—paving the road for improved risk prevention—have been thoroughly analysed for various geographical regions. Additionally, evidence‐based approaches now allow the introduction of novel guideline recommended medical therapies (i.e. sodium‐glucose transporter 2 inhibitors, and iron supplementation) while basic and translational research aim to explore additional molecular targets for future heart failure diagnostics and medications. All above aspects are addressed in this article, where a selection of articles published in the ESC Heart Failure journal in 2023 are highlighted. The editors are confident that the scientific contributions of ESC Heart Failure effectively served a highly relevant area of cardiovascular research last year.

Funder

National Research, Development and Innovation Office

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3